Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Charting oncogenicity of genes and variants across lineages via multiplexed screens in teratomas

ABSTRACT: Charting oncogenicity of genes and variants across lineages via multiplexed screens in teratomas

PROVIDER: PRJNA715235 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13994911_1.fastq.gz	Fastqsanger.gz
	SRR13994911_2.fastq.gz	Fastqsanger.gz
	SRR13994912_1.fastq.gz	Fastqsanger.gz
	SRR13994912_2.fastq.gz	Fastqsanger.gz
	SRR13994913_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 168

Similar Datasets

Charting oncogenicity of genes and variants across lineages via multiplexed screens in teratomas

Project description:To deconstruct tissue-specific effects of genes and variants on proliferative advantage and transformation potential we developed a novel approach, harnessing single-cell cancer driver screens in teratomas coupled with hit enrichment by serial teratoma reinjection, to simultaneously screen drivers across multiple lineages in vivo. Using this system, we analyzed population shifts and lineage-specific enrichment for 51 cancer associated genes and gene variants, profiling over 100,000 cells spanning over 20 lineages, across two rounds of serially injected teratomas. We confirmed that c-MYC alone or combined with myristoylated AKT1 potently drives proliferation in progenitor neural lineages, demonstrating signatures of malignancy. These drivers directed teratoma development to lineages representative of pediatric tumors such as medulloblastoma and rhabdomyosarcoma. Additionally, mutant MEK1 (S218D/S222D) provides a proliferative advantage in mesenchymal lineages like fibroblasts.

2021-08-31 | GSE169114 | GEO

Charting oncogenicity of genes and variants across lineages via multiplexed screens in teratomas.

Project description:Deconstructing tissue-specific effects of genes and variants on proliferation is critical to understanding cellular transformation and systematically selecting cancer therapeutics. This requires scalable methods for multiplexed genetic screens tracking fitness across time, across lineages, and in a suitable niche, since physiological cues influence functional differences. Towards this, we present an approach, coupling single-cell cancer driver screens in teratomas with hit enrichment by serial teratoma reinjection, to simultaneously screen drivers across multiple lineages in vivo. Using this system, we analyzed population shifts and lineage-specific enrichment for 51 cancer associated genes and variants, profiling over 100,000 cells spanning over 20 lineages, across two rounds of serial reinjection. We confirmed that c-MYC alone or combined with myristoylated AKT1 potently drives proliferation in progenitor neural lineages, demonstrating signatures of malignancy. Additionally, mutant MEK1 S218D/S222D provides a proliferative advantage in mesenchymal lineages like fibroblasts. Our method provides a powerful platform for multi-lineage longitudinal study of oncogenesis.

| S-EPMC8496177 | biostudies-literature

CHARTING AND PROBING THE ACTIVITY OF ADARS IN HUMAN DEVELOPMENT AND CELL-FATE SPECIFICATION

Project description:Adenosine deaminases acting on RNA (ADARs) impact diverse cellular processes and pathological conditions. While we possess important insights into their roles in adult tissues, their functions in early cell fate specification remain less understood. To address this, we devised a comprehensive framework to investigate ADARs in human development. We began by charting time-course RNA editing profiles in human organs from fetal to adult stages, enabling broad insights into RNA editing trends across diverse tissues. Next, we utilized hPSC differentiation to experimentally probe ADARs across specific tissue-types, harnessing brain organoids as neural specific, and teratomas as pan-tissue developmental models. We found that time-series teratomas faithfully recapitulated developmental trends observed in fetal tissue. Motivated by this, we conducted pan-tissue, single-cell CRISPR-KO screens of ADARs in teratomas to assess their role in cell-fate specification. Knocking out ADAR1 led to a global decrease in RNA editing across all germ-layers. Intriguingly, we observed a significant fitness defect in mesodermal tissues, and an enrichment of adipogenic cells, revealing a novel role for ADAR1 in mesenchymal differentiation. Collectively, we developed a multi-pronged framework charting time-resolved RNA editing profiles in fetal and fetal-like organ tissues, thereby shedding light on the role of ADARs in development and cell fate-specification.

2024-10-24 | GSE248941 | GEO

Enhanced Phase Separation Mediated Oncogenicity

Project description:Enhanced Phase Separation Mediated Oncogenicity

| PRJNA870439 | ENA

Arrayexpression analysis of Evi-overexpressing teratomas

Project description:Canonical and non-canonical Wnt signaling play key roles during development and tumorigenesis. In this study we compared gene expression in teratomas grown from mouse embryonic stem cells that overexpress Evi/Wls and teratomas from normal embryonic stem cells cells.

2016-03-06 | E-MTAB-3995 | biostudies-arrayexpress

Gene expression analysis of HESC derived teratomas

Project description:Gene expression analysis of human embryonic stem cell derived tumors (teratomas).

2008-11-14 | GSE13586 | GEO

Enhanced Phase Separation Mediated Oncogenicity [HiC]

Project description:Enhanced Phase Separation Mediated Oncogenicity [HiC]

| PRJNA1003850 | ENA

Gene expression altered by Sox2 T258A mutation in teratomas

Project description:mRNA expression profiles of teratomas derived from mouse embryonic stem cells containing Sox2 WT and Sox2 T258A mutations

2021-06-06 | GSE176212 | GEO

Enhanced Phase Separation Mediated Oncogenicity [RNA-Seq]

Project description:Enhanced Phase Separation Mediated Oncogenicity [RNA-Seq]